Intelligent Drug Development
Trials and Errors in Clinical Research
- Publisher's listprice GBP 60.00
-
28 665 Ft (27 300 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 2 867 Ft off)
- Discounted price 25 799 Ft (24 570 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
28 665 Ft
Availability
printed on demand
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher OUP USA
- Date of Publication 29 May 2014
- ISBN 9780199974580
- Binding Hardback
- No. of pages232 pages
- Size 156x234x17 mm
- Weight 535 g
- Language English
- Illustrations 25 illustrations 0
Categories
Short description:
A guide to making the drug-development process more efficient, by way of analyzing various steps in clinical research.
MoreLong description:
Clinical research is heavily regulated and involves coordination of numerous pharmaceutical-related disciplines. Each individual trial involves contractual, regulatory, and ethics approval at each site and in each country. Clinical trials have become so complex and government requirements so stringent that researchers often approach trials too cautiously, convinced that the process is bound to be insurmountably complicated and riddled with roadblocks. A step back is needed, an objective examination of the drug development process as a whole, and recommendations made for streamlining the process at all stages.
With Intelligent Drug Development, Michael Tansey systematically addresses the key elements that affect the quality, timeliness, and cost-effectiveness of the drug-development process, and identifies steps that can be adjusted and made more efficient. Tansey uses his own experiences conducting clinical trials to create a guide that provides flexible, adaptable ways of implementing the necessary processes of development. Moreover, the processes described in the book are not dependent either on a particular company structure or on any specific technology; thus, Tansey's approach can be implemented at any company, regardless of size. The book includes specific examples that illustrate some of the ways in which the principles can be applied, as well as suggestions for providing a better context in which the changes can be implemented. The protocols for drug development and clinical research have grown increasingly complex in recent years, making Intelligent Drug Development a needed examination of the pharmaceutical process.
Table of Contents:
PART 1: SETTING THE SCENE
Introduction: Cutting the Gordian Knot
Chapter 1: Aiming for Excellence
PART 2: PLANNING: FROM CHAOS TO COSMOS
Chapter 2: The Target Product Profile and Its Uses
Chapter 3: Planning the Individual Clinical Trial
PART 3: THE PRACTICABLE PROTOCOL
Chapter 4. Distilling the Essence of the Protocol: The Protocol Synopsis
Chapter 5. Redistillation: Eliminating Impurities By Carrying Out Protocol
Chapter 6. The Optimal Blend: The approved Synopsis and the Final Protocol
PART 4: THE SPONSOR, THE PHYSICIAN AND THE PATIENT; THE ETERNAL CLINICAL TRIAL TRIANGLE
Chapter 7: Of Chickens and Eggs: The Sponsors' Dilemma
Chapter 8: Clinician or Clinical Trialist: the Physicians' Dilemma
Chapter 9: what About the Customer? the Patients' Dilemma
PART 5: AND ANOTHER THING...
Chapter 10: About Time: Making Meetings Matter
Chapter 11: The Brain-Scrambling, Fit-Inducing, Mind-Numbing Technicolor
